WJET Erie on MSN1mon
Drugmaker to settle nearly 80,000 Zantac lawsuits for up to $2.2 billion
UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...
Optimistic Buy Rating for GlaxoSmithKline: Undervalued Stock with Promising Growth Prospects
GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Smith from ...
As Drug Maker Stocks Fall, Pressure Builds On PhRMA To Derail RFK Jr.
Stocks of major drug makers and biotech companies tumbled in the first full day of trading after Donald Trump announced that ...
TipRanks on MSN3d
GSK’s Blenrep Nears FDA Review for Myeloma
GlaxoSmithKline (GB:GSK) has released an update. GlaxoSmithKline’s Blenrep combinations for treating relapsed multiple myeloma have been accepted ...
OPPI Annual Summit Presents the Roadmap on Becoming the Pharma Powerhouse to the World
PRNewswire New Delhi [India] November 28 The Organisation of Pharmaceutical Producers of India OPPI organized its flagship ...
pharmaphorum1d
FDA clears GSK's Priorix, first new MMR vaccine in 50 years
With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmithKline's venerable vaccine Priorix for sale in the US looks timely. Priorix was first launched in Europe ...
BBC4y
GlaxoSmithKline tells staff to turn off Covid app at work
Pharmaceuticals giant GlaxoSmithKline has told thousands of staff to turn off the NHS Covid-19 app while at work. It told them to switch off the Bluetooth contact-tracing feature at its research ...
Nature3y
How GlaxoSmithKline is advancing efficient drug development in haematologic malignancies
At GlaxoSmithKline, we never lose sight of the fact that patients are at the core of what we do and that millions of lives are impacted by cancer. The patient’s voice is at the heart of our ...
moneycontrol.com29d
GlaxoSmithKline Pharmaceuticals Q2 net profit rises 16% to Rs 252 crore
GlaxoSmithKline said its key brands held their market share and continued to stay in line with the respective category performance. GlaxoSmithKline Pharmaceuticals on October 29 reported a 16 ...
Wall Street Journal1d
GlaxoSmithKline Pakistan Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
moneycontrol.com6y
Glaxosmithkline Consumer
Nomura cuts GSK Consumer to 'reduce' on high valuations Nomura Financial Advisory and Securities India has downgraded GlaxoSmithKline Consumer Healthcare to "reduce" from "buy" citing high ...
Wall Street Journal4y
GlaxoSmithKline Pharmaceuticals Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...